300 reports

  • AUSTRALIA PHARMACEUTICALS MARKET VALUE: $ BILLION, 2013-17
  • AUSTRALIA PHARMACEUTICALS MARKET SHARE: % SHARE, BY VALUE, 2017

Pharmaceuticals in Australia Summary Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including...

  • Pharmaceutical
  • Australasia
  • Australia
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • Federal funding for the Pharmaceutical Benefits Scheme
  • AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED - INDUSTRY SEGMENT PERFORMANCE

Sugar pills: Firms have pursued non-PBS revenue streams to support revenue growth Abstract Pharmaceuticals Wholesaling in Australia Industry companies wholesale pharmaceutical products, including prescription drugs, over-the-counter medicines and complementary or alternative medicines. Industry companies...

  • Pharmaceutical
  • Pharmacy
  • Australia
  • Demand
  • Federal funding for the Pharmaceutical Benefits Scheme
  • PHARMACEUTICAL COMPANIES WITH A PRESENCE IN AUSTRALIA INCLUDE MERCK,

In poor health: Price disclosures and growing competition have ailed industry revenue Abstract Pharmaceutical Product Manufacturing in Australia The industry comprises companies that manufacture medicinal and pharmaceutical products for human use from both synthetic (chemical) and natural...

  • Pharmaceutical
  • Australia
  • Demand
  • Trade
  • Demand from pharmaceutical product manufacturing
  • Major market segmentation (2018-19)

Hard to swallow: Falling demand from manufacturers has reduced industry revenue Abstract Pharmaceuticals Packing and Labelling Services in Australia Industry operators provide packaging and labelling services to manufacturers and wholesalers of pharmaceutical goods on contract. This report covers...

  • Pharmaceutical
  • Australia
  • Demand
  • Forecast
  • Amcor Limited
  • Capital intensity
  • INDUSTRY DEFINITION

High capital intensity is more than $##. ## of capital to $## of labour; medium is $##. ## to $##. ## of capital to $## of labour; low is less than $##. ## of capital for every $## of labour.

  • Non-Store Retail
  • Pharmaceutical
  • Pharmacy
  • Australia
  • Demand

GlobalData QIMR Berghofer Medical Research Institute' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Pharmaceutical
  • Therapy
  • Australia
  • Social Conditions
  • Atara Biotherapeutics, Inc.
  • Distribution of enterprises vs. population
  • Capital intensity

High capital intensity is more than $##. ## of capital to $## of labour; medium is $##. ## to $##. ## of capital to $## of labour; low is less than $##. ## of capital for every $## of labour.

  • Pharmaceutical
  • Veterinary Healthcare
  • Australia
  • Demand
  • Virbac SA
  • Australian Chemical and Pharmaceutical Plants construction Output, Refurbishment by
  • Australian Chemical and Pharmaceutical Plants construction Output, Refurbishment by

Synopsis Timetric’s "Chemical and Pharmaceutical Plants (Construction) in Australia: Market Analytics by Category & Cost Type to 2022" contains historic and forecast market data for the chemical and pharmaceutical plants category in Australia, it also provides detailed breakdown of the data by construction activity (new...

  • Construction
  • Pharmaceutical
  • Australia
  • Market Size
  • Supply
  • Australian Chemical and Pharmaceutical Plants Construction, Repair & Maintenance
  • Australian Chemical and Pharmaceutical Plants Construction, Refurbishment Output

Synopsis Timetric’s 'Chemical and Pharmaceutical Plants Construction in Australia to 2020: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance,...

  • Construction
  • Pharmaceutical
  • Australia
  • Market Size
  • Supply
  • Ego Pharmaceuticals Pty Ltd, History
  • Ego Pharmaceuticals Pty Ltd - Threats

Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Pharmaceutical
  • Australia
  • Company
  • Forecast
  • Trade
  • PHARMACEUTICALS AND MEDICAL EQUIPMENT IN AUSTRALIA
  • Regulatory Pricing Pressures on Pharmaceuticals Expected To Persist

The industry’s turnover experienced a solid growth in 2017 thanks to significant export gains, and greater sales to the domestic market, especially directly to Australian consumers. Although contributions by the country’s households to prescription drug expenditure remained virtually unchanged, spending on over-the-counter drugs registered...

  • Pharmaceutical
  • Australia
  • Demand
  • Trade

2018 and Beyond: Australia Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025 ## Table of Contents ##. ## List of Tables ##. ## List of Figures ## Executive Summary ##. ## Australia Pharmaceutical and Healthcare Industry Snapshot ##. ## Australia

  • Pharmaceutical
  • Australasia
  • Australia
  • Demand
  • Market Size

Australian Pharmaceutical Industries Limited Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report ## Table of Contents ##. ## List of Tables ##. ## List of Figures ## Introduction to the Company ##. ## Australian Pharmaceutical Industries Limited- Key

  • Pharmaceutical
  • Australasia
  • Australia
  • Market Size
  • 4.2 Pharmaceutical & Healthcare Online Ad Spend
  • Australia Pharmaceutical & Healthcare Brands' Online Advertising Spend - Breakdown by Marketing Objective (%), 2015 vs. 2020

Online advertising spend by pharmaceutical & healthcare brands in Australia stood at US$170 million by end of 2015, accounting for 3.2% of total online advertising. During 2011-2015, online advertising in this industry has increased at a CAGR of 18.8%. This growth is expected to continue in 2016 with brands expected to spend US$198 million,...

  • Online Advertising
  • Pharmaceutical
  • Social Network
  • Australia
  • Forecast
  • PRICE BUILD UP
  • PRICING

However, the Pharmaceutical Benefits Pricing Authority (PBPA) was disbanded on ## April 2014 (see ' Disbanding of the PBPA', above).

  • Health Services
  • Healthcare
  • Hospital
  • Pharmaceutical
  • Australia
  • 5.2 Pharmaceutical & Healthcare Social Media Ad Spend
  • Australia Pharmaceutical & Healthcare Brands' Advertising Spend on Social Media - Breakdown by Marketing Objective (%), 2015 vs. 2020

Social media advertising spend by pharmaceutical & healthcare brands in Australia stood at US$27 million by end of 2015, accounting for 2.7% of total social media advertising. During 2011-2015, social media advertising in this industry has increased at a CAGR of 32.1%. This growth is expected to continue in 2016 with brands expected to spend...

  • Advertising
  • Pharmaceutical
  • Social Network
  • Australia
  • Forecast
  • Teva Pharmaceutical Industries Limited: key financials ($)
  • Teva Pharmaceutical Industries Limited: key financial ratios

Generics in Australia Summary Generics in Australia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics...

  • Pharmaceutical
  • Australia
  • Apotex Inc.
  • Aspen Pharmacare Holdings Limited
  • Mylan Inc.
  • KEY PHARMACEUTICALS PTY LTD

Key Pharmaceuticals’ strategy involves growing its share through the offer of safe, effective and high-quality products. The company prides itself on being Australian-owned and operated. It owns the majority of its brands, while some are also manufactured under exclusive licensing and distribution agreements. Euromonitor International...

  • OTC
  • Pharmaceutical
  • Weight Loss
  • Australia
  • Demand

OVERVIEW IT OPERATES IN ## BUSINESS DIVISIONS ##) CONSUMER ##) PHARMACEUTICAL ##. ##. ##.

  • Pharmaceutical
  • Australia
  • Market Size
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • 4.2 Chemical and Pharmaceutical Plants construction Output Value
  • 4.1 Chemical and Pharmaceutical Plants construction Output Value,

Synopsis Timetric’s "Industrial Construction Market in Australia: Market Size, Growth and Forecast Analytics to 2022" contains historic and forecast market data for the industrial construction market in Australia, with a detailed breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment...

  • Construction
  • Pharmaceutical
  • Australia
  • Market Size
  • Supply
  • Bargaining Power of Suppliers in the Australian Generics Industry
  • Bargaining Power of Suppliers

The company is one the world' s largest active pharmaceutical ingredients (APIs) producers.

  • Pharmaceutical
  • APAC
  • Australia
  • United States
  • World
  • 3.1.2 Pharmaceutical Exports and Imports
  • 3.1 PHARMACEUTICAL MARKET

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia Summary GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia”. The report is an essential source of information on and analysis of the healthcare,...

  • Pharmaceutical
  • Australia
  • Market Size
  • AstraZeneca PLC
  • Pfizer Inc.

OVERVIEW P A G E | ## ## ## IT OPERATES IN ## BUSINESS DIVISIONS ##) CONSUMER ##) PHARMACEUTICAL ##. ##. ##.

  • Pharmaceutical
  • Australia
  • Market Size
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Volume (Million Square Feet), 2013 - 2022
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Value (AUD Million), 2013 - 2022

Report Description The construction industry in value terms is expected to record a CAGR of 7.5% to reach US$ 293.4 billion by 2022. The industrial building construction market in value terms is expected to reach US$ 4.5 billion in 2018. This report from ConsTrack360 provides data-centric analyses on industrial construction...

  • Industrial Construction
  • Pharmaceutical
  • Australia
  • Forecast
  • Market Size
  • 27.4 LEGAL AND REGULATORY

BETWEEN 1994 AND 2005, PATERSON SERVED AT ROCHE PHARMACEUTICALS.

  • Pharmaceutical
  • Australia
  • Forecast
  • Medtronic, Inc.
  • Olympus Corporation

Sigma Pharmaceuticals Ltd.

  • Pharmaceutical
  • Australasia
  • Australia
  • Market Competition
  • COPD: KEY METRICS IN THE EIGHT MAJOR PHARMACEUTICAL MARKETS
  • Strengths

PharmaPoint: Chronic Obstructive Pulmonary Disease - Global Drug Forecast and Market Analysis to 2025 Summary COPD is a progressive lung disease characterized by an abnormal inflammatory response and airflow obstruction that is not fully reversible. Chronic airflow limitation is caused by both small airway diseases,...

  • Pharmaceutical
  • Australia
  • North America
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Pharmaceutical sales
  • Pharma and biotech

Disease trends;Healthcare;Healthcare;Pharmaceuticals and biotechnology;Healthcare;Provision;Healthcare;Spending NCAIS: 62 SIC: 80

  • Healthcare
  • Pharmaceutical
  • Australia
  • Demand
  • Social Conditions
  • Pharma and biotech
  • Pharmaceutical sales

Healthcare expenditure in Australia accounted for 9.4% of GDP in 2014, according to the World Health Organisation (WHO). The Economist Intelligence Unit estimates that this rose to 9.6% in 2016, and will rise further to 9.7% in 2021. According to the WHO, 67% of Australia's healthcare spending in 2014 came from general...

  • Healthcare
  • Pharmaceutical
  • Australia
  • Demand
  • Forecast
  • ELI LILLY'S RA PORTFOLIO ASSESSMENT, 2016
  • BMS' RA PORTFOLIO ASSESSMENT, 2016

FIRSTWORD PHARMA.

  • Pharmaceutical
  • Australia
  • AbbVie Inc.
  • Pfizer Inc.
  • Remicade group